BOSTON, MA – April 2, 2012 – Applied Tissue Technologies, LLC a leading manufacturer of wound healing technologies, today announced the latest publication describing the use of the XPANSION Skin Grafting Instrument Kit in the March, 2012 Journal of Plastic and Reconstructive Surgery. In the study authored by Hackl, et. al, micrografts implanted into a porcine-model were shown to expand in a 1:100 ratio, resulting in a complete epithelialization of both healthy and diabetic wounds by 14 days. In comparison, non-transplanted wounds demonstrated 62% and 49% epithelialization in healthy and diabetic wounds respectively, at the same time point.
“We are very pleased with the results of this study and look forward to continued adoption of the XPANSION technique as physicians and patients experience the benefits,” said Neil Weber, Vice President of Sales and Marketing. “Wound care, particularly in the diabetic population, remains a big health care challenge in most developed markets and it is critical that we offer appropriate and cost-effective therapies to treat these patients to not only heal their wounds but avoid greater medical complications for them down the road.”
Please refer to the Journal of Plastic and Reconstructive Surgery for more information on this study. For more information on the XPANSION kit, please contact Applied Tissue Technologies at 781.239.82323 or visit us at www.appliedtissue.com.